Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Research and Markets: China Blood Products Industry Report, 2007-2008 Out Now


Print article Print article
Refer this article Refer to a friend
© Business Wire 2009
2009-01-09 17:07:01 -

Research and Markets (www.researchandmarkets.com/research/8ce446/china_blood_produc) has announced the addition of the "China Blood Products Industry Report, 2007-2008" report to their offering.


China blood products industry is all along comparatively independent from global blood products industry. In the year of 1986, according to the rules from Ministry of Health, China prohibited the import of blood products except HAS. However, since

2002, HAS import had been also prohibited from BSE disease regions.


Considering the short supply of domestic blood products, in May 2008, State Council of China adjusted the import tariff of HSA products from 3% to zero during 1st Jun 2008 to the end of Dec 2008. However, due to the HAS price in China market lower than international market, foreign companies are seldom willing to export.


China has totally 33 blood products manufacturers. In the year of 2007, the blood products market scale in China was about CNY 6 billion. China has a great demand for albumin, due to the large number of liver disease patients; the other blood products also have a considerable demand in China such as gammaglobulin, immunoglobulin and plasma thromboplastin component.


Based on the authoritative statistics from General Administration of China Customs, Pharmaceutical Industry Association and National Bureau of Statistics, this report is focused on the actuality of China blood products industry, as well as its development trend and investment opportunities and risks.


Key Topics Covered:


- 1. Overview of China Blood Products Industry
- 2. China Blood Plasma Market
- 3. Development of Global Blood Products Industry
- 4. Key Blood Products
- 5. Key Manufacturers in China
- 6. Investment Analysis
- Executive Summary
Companies Mentioned:


- Hualan Biological Engineering Co., Ltd
- Shanghai RAAS Blood Products Co., Ltd
- Shanghai Institute of Biological Products
- Chengdu Rongsheng Pharmaceuticals Co., Ltd
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd
- Guiyang Qianfeng Biological Product Liability Co., Ltd.
For more information visit www.researchandmarkets.com/research/8ce446/china_blood_produc.








Research and Markets

Laura Wood

Senior Manager

press@researchandmarkets.com

Fax from USA: 646-607-1907

Fax from rest of the world: +353-1-481-1716


Disclaimer: (c) 2009 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com